[Skip to Navigation]
In This Issue of JAMA Otolaryngology
June 2015


JAMA Otolaryngol Head Neck Surg. 2015;141(6):495. doi:10.1001/jamaoto.2014.2157

The application of robotic surgery for the treatment of oropharyngeal squamous cell carcinoma has provided another therapy option. Choby and associates studied quality-of-life (QOL) outcomes from 34 patients with oropharyngeal squamous cancer who were treated only with transoral robotic surgery between May 2010 and March 2014. Patients completed the University of Washington QOL questionnaire 1, 6, 12, and 24 months after surgery. As expected, most patients had T1 and T2 disease with N0 or N1 necks. Two patients died during follow-up. Statistically significant improvements were noted in chewing, swallowing, pain, and activity, showing acceptable short- to moderate-term QOL parameters.

Add or change institution